Home » Biovitrum Aims to Spin Out Cambridge Biotechnology
Biovitrum Aims to Spin Out Cambridge Biotechnology
Biovitrum AB announced the initiation of a process aiming to spin out its small molecule UK based R&D subsidiary Cambridge Biotechnology (CBT) and a range of primary care projects.
MSNBC
MSNBC
Upcoming Events
-
07May
-
14May
-
30May